Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Echinocandins Versus Azoles as First-line Therapy for the Treatment of Candidemia in Intensive Care Units

NCT03799172 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT03799172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03799172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Echinocandins Versus Azoles as First-line Therapy for the Treatment of Candidemia in Intensive Care Units
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
November 1, 2018
Completion date
September 1, 2019
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

candidemia